SCL Science Inc (246960)

Currency in KRW
1,877
+93(+5.21%)
Delayed Data·
246960 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,8001,946
52 wk Range
1,5043,490
Key Statistics
Bid/Ask
1,841.00 / 1,878.00
Prev. Close
1,784
Open
1,800
Day's Range
1,800-1,946
52 wk Range
1,504-3,490
Volume
19.95K
Average Volume (3m)
82.81K
1-Year Change
-42.8615%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
246960 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Healthcare Equipment & Supplies industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
May 15, 2026
EPS / Forecast
-25.00 / --
Revenue / Forecast
7.66B / --
EPS Revisions
Last 90 days

246960 Income Statement

Compare 246960 to Peers and Sector

Metrics to compare
246960
Peers
Sector
Relationship
P/E Ratio
−19.2x8.2x−0.4x
PEG Ratio
−0.430.060.00
Price/Book
2.6x1.3x2.6x
Price / LTM Sales
2.2x2.2x3.1x
Upside (Analyst Target)
-55.3%48.3%
Fair Value Upside
Unlock19.3%6.1%Unlock

SCL Science Inc. produces medical hemostatic agents using biomimetic technology. Its products include BiMM (Bio-inspired Medical Materials) that reacts immediately with blood; Endoseal, which is used for specialized indication of gastrointestinal bleeding; InnoSeal, a hemostatic agent that is used in various surgical fields, such as cardiology, radiology, and neurosurgery; Jelly Seal, a hemostasis and sealing products; STOP, a non-bleeding intravascular injection; Film that prevents leakage at intestinal and vascular anastomosis sites; InnoLOCK and InTro vascular interventional procedure items; and operates bio-logistics business. The company also engages in conducting clinical trial analysis services related to new drug development, in vitro diagnostic medical device performance evaluation, transportation of pharmaceuticals and clinical trial samples, etc. The company was formerly known as InnoTherapy, Inc. and changed its name to SCL Science Inc. in March 2024. SCL Science Inc. was founded in 2010 and is headquartered in Seoul, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
17.98M52.86%30.95B
Public Companies & Retail Investors
16.03M47.14%27.59B
Total
34.01M100.00%58.54B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
SCL Holdings Co.,Ltd.35.64%12,121,16420,860,523
Seoul Clinical Laboratories13.21%4,494,5207,735,069

FAQ

What Is the SCL Science (246960) Stock Price Today?

The SCL Science stock price today is 1,877 KRW.

What Stock Exchange Does SCL Science Trade On?

SCL Science is listed and trades on the KOSDAQ.

What Is the Stock Symbol for SCL Science?

The stock symbol for SCL Science is "246960."

What Is the SCL Science Market Cap?

As of today, SCL Science market cap is 60.68B KRW.

What Is SCL Science's Earnings Per Share (TTM)?

The SCL Science EPS (TTM) is -93.

From a Technical Analysis Perspective, Is 246960 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has SCL Science Stock Split?

SCL Science has split 1 times.

What is the current trading status of SCL Science (246960)?

As of Jul 08, 2026, SCL Science (246960) is trading at a price of 1,877 KRW, with a previous close of 1,784 KRW. The stock has fluctuated within a day range of 1,800 KRW to 1,946 KRW, while its 52-week range spans from 1,504 KRW to 3,490 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.